Policy

Policy for knowledge exchange, commercialisation and translation

From:
BBSRC
Published:

BBSRC position

UK Research and Innovation (UKRI) has a mission to advance knowledge, improve lives and drive UK growth. As part of this mission, the Biotechnology and Biological Sciences Research Council (BBSRC) will work to progress the research and capabilities it funds into real-world outcomes. This may lead to direct financial impact through commercialisation or through translation into wider economic and societal benefits.

BBSRC is committed to supporting the progression of bioscience discoveries into new products, processes and services. BBSRC will also support knowledge exchange activities that enable novel insights from bioscience research to inform practices, policies and knowledge. BBSRC recognises that the translation of research outcomes depends upon complex pathways that enable both direct and indirect benefits to individuals and organisations.

Benefits will include:

  • improving the effectiveness of public goods and services and delivery of public policy
  • catalysing economic growth and competitiveness
  • safeguarding the environment and future resilience
  • enhancing people’s quality of life in UK and overseas

BBSRC will do this through a strategy that enables and incentivises a wide range of knowledge exchange, commercialisation and translation (KECT) activities. This includes directly through BBSRC funding schemes and in partnership with other organisations.

Principles underlying BBSRC’s position

Impact, translation, commercialisation and knowledge exchange

Excellence in all forms of research and knowledge exchange activities is at the core of BBSRC support for knowledge exchange, commercialisation and translation.

BBSRC recognises that all excellent research will advance knowledge but accepts that not all research will be translated to practical application. Impact can be defined as the long-term intended or unintended effect research and innovation have on society, economy and the environment, to individuals, organisations and the wider global population.

BBSRC is a key enabler in delivering UKRI’s vision for commercialisation. UKRI coordinates expertise from across nine research councils, including BBSRC, to improve research commercialisation outcomes by influencing and incentivising, maximising support, and advocating for knowledge exchange, commercialisation and translation.

BBSRC also acknowledges that knowledge exchange is a broader activity than pure commercialisation or translation. Progression towards benefit and impacts requires a wide range of knowledge exchange and commercial activities including engagement with users of research outcomes in business, public and third sectors. Interactions will be two-way, complex and take a variety of forms. Success will be achieved through many different channels and mechanisms and will deliver benefit over varying timescales.

BBSRC’s aim for KECT is not solely to generate a financial return to an individual, institution or UKRI, but to realise the potential for bioscience research to deliver the widest range of benefits.

For example, knowledge exchange with some organisations, particularly in the non-commercial and policy environments, are unlikely to generate income. However, these engagements can be central to delivering benefit, for example through improved public policy or user engagement, and are regarded as a valuable outcome.

Evidence and evaluation

BBSRC recognises that it is critical to capture the outputs, outcomes and impact of the research funded by the council. This allows BBSRC to demonstrate the wider value and benefit of these outcomes to UK society and the economy. BBSRC expects researchers to support monitoring and evaluation efforts and commits to only collecting evidence about KECT outcomes that is necessary, relevant and actionable.

BBSRC regularly conducts evaluations of funding programmes and portfolios, including economic impact analysis. This includes BBSRC’s translation and commercialisation programmes and spin-outs portfolio. These evaluations highlight the extensive economic impact of the commercialisation of BBSRC-funded research and the importance of knowledge exchange and translation activities.

People, culture and strategy

Researchers who undertake knowledge exchange and commercialisation activities must be incentivised through recognition and rewarded by their host institutions and the research community. This will include rewards to inventors where appropriate. It will also include wider approaches to recognise the commitment and success of individuals and groups in achieving benefit through the application and propagation of research outcomes.

BBSRC expects the universities and institutes in receipt of BBSRC funding to have a strategy and vision for KECT within the context of their diverse missions, areas of research and user communities.

BBSRC supports voluntary frameworks that seek to develop knowledge exchange in higher education institutes , such as the KE Concordat.

How BBSRC will deliver the policy

Knowledge Exchange and Commercialisation Unit

BBSRC created the Knowledge Exchange and Commercialisation Unit to lead on the council’s strategy for KECT, including monitoring related outcomes and horizon-scanning. The unit also provides specialist support for developing BBSRC innovation infrastructure assets and promoting enterprise and venture.

National Research and Innovation Campuses

BBSRC supports five regional campuses, each centred on one or more strategically funded institute, and part of the wider cohort of UKRI campuses and clusters that drive collaboration, innovation and research translation. The campuses combine both public and private investments to deliver innovation infrastructure that is of strategic importance to the UK.

Institutes strategically funded by BBSRC

BBSRC invests in KECT at the institutes strategically funded by BBSRC. BBSRC’s goal in providing this funding is to enable institutes to take a longer term and more strategic approach to delivering impact through KECT.

Research community

BBSRC has developed a wide range of mechanisms to support and encourage KECT. These can be accessed by researchers, KECT professionals, innovators and users, as appropriate to their needs. Mechanisms include, but are not limited to:

  • support for collaborative and translational research
  • collaborative training and people exchange
  • enterprise and entrepreneurial skills training
  • enterprise and investment support
  • approaches to incentivise and celebrate success

In addition, researchers are expected to consider, as part of any research grant proposal, how the proposed research might improve lives and grow the economy. BBSRC also expects that those researchers that receive funding will capture and propagate the outputs, outcomes, and impact of their research.

Partnership: user community

BBSRC research underpins the needs of a variety of users, for example established industry, startups and spin-outs, or bioscience investors, and business sectors often with differing requirements in relation to KECT. BBSRC uses a range of mechanisms to work in partnership with these stakeholders to ensure an understanding of the routes to application and that knowledge exchange support mechanisms are fit for purpose.

Partnership: other funders

BBSRC will work in partnership with other councils within UKRI. BBSRC is positioned within a network of other public funders including government departments and devolved administrations. BBSRC also builds connections with charitable and private investors, businesses and organisations.

BBSRC works in partnership with these organisations to ensure a greater understanding of the way research outcomes have practical application and to deliver collaborative or joined up approaches to support.

Public engagement and science communication

BBSRC is committed to ensuring transparency in all processes associated with the council’s support for knowledge exchange and commercialisation. Researchers are expected to consider how their research and knowledge exchange activities are consistent with UKRI’s approach to public engagement and science communication. This should lead them to consider how their proposed research, knowledge exchange, public engagement and science communication activities address social issues, including public aspirations and concerns.

BBSRC publicises outcomes in ways that enable the wider public to engage with the outputs of research and how potential applications may impact upon society and the economy.

Knowledge Exchange Concordat

The KE Concordat is a framework to enhance collaboration and knowledge sharing with eight guiding principles that universities and other research organisations can sign up to. It is managed by Knowledge Exchange UK after development by Universities UK and Research England.

Definitions supporting the policy

Knowledge exchange

Knowledge exchange describes the processes, mechanisms, networks and relationships that enable knowledge derived from research activity to move between organisations and into wider society. The term is applied to the sharing and use of knowledge that has the potential to drive innovations that generate and improve products, processes, services and practices. This also includes using and sharing knowledge in ways that may inform and change practices, policies and perceptions.

Commercialisation

Commercialisation describes the process by which the outcomes of research activity are brought to the marketplace through the development of new products, processes, services or technologies. There will be some commercial return involved in the process relating to the potential value of the assets, while there may also be wider impact on society through the adoption of the innovation. Commercialisation is therefore an important route to impact, especially where markets are an important gateway to societal adoption.

The process involves the identification of research and innovation that have potential commercial interest and designing and executing appropriate strategies for exploiting this research. This will include the protecting and managing of the rights to intellectual property. The process is typically undertaken with the assistance of dedicated offices in universities, research institutes and companies. Strategies can include the creation of licensing agreements or joint ventures, partnerships or spin-out companies.

Translational research

Translational research helps turn early-stage innovations into new technologies, products and approaches, advancing the innovation to the point where it becomes attractive for further development by a new company, existing businesses or public services. Academic and industrial research activity produces many new discoveries and inventions that have the potential to lead to marketable products. However, progressing innovations to market often requires further work to establish scientific or technical proof-of concept, bringing together collaborators with the right expertise to develop a given product, or engaging with potential users or markets.

While translational research has the potential to help bridge this gap between basic research and marketable products, it may not achieve this fully. For example, translational research may advance the research outcomes to the point where intellectual property may be exemplified and consolidated, or technology may be brought to a stage at which commercial value can be ascribed to it and its potential defined more accurately.

Intellectual assets

An intellectual asset is an item that has monetary value, or which can be used to add value to an organisation. Within the context of this policy the term relates specifically to the assets associated with research activity and capabilities. Some assets are tangible in that they exist physically and have a readily defined value. Other assets are intangible and do not exist physically nor have they a readily defined value. Intellectual capital is defined as the combined value of the intangible assets of an organisation, and will include for example people, technology, knowledge, processes and procedures.

Intellectual assets are a key component of intellectual capital. These are the intangible assets that are or can be recorded (or written down, codified). A subset of these assets is intellectual property (IP). This will include, for example, technical information, know-how, methodologies and IP rights such as patents, plant breeders’ rights, trademarks, copyright and registered designs that are legally protected by the statute law.

UKRI has expectations around the identification, management and exploitation of knowledge assets including IP as set out in the UKRI intellectual property strategic statement.

Resources relevant to the policy

Commercialising your research with UKRI

UKRI intellectual property strategic statement

The Knowledge Assets Spin-out Guide – Government Office of Technology Transfer

Knowledge Asset Management (KAM) Hub – Intellectual Property Office

University and business collaboration agreements: Lambert Toolkit

University Spin-Out Investment Terms (USIT)

Further reading

Deepening university-investor links (Hickson Review), February 2026

Economic evaluation of BBSRC’s translational funding, February 2025

Economic impact assessment of BBSRC attributable spin-outs, February 2024

Independent review of university spin-out companies, Professor Irene Tracey and Doctor Andrew Williamson, 2023

Bioscience: lost in translation?, Innovation Caucus, 2022

Business-university research collaborations, Professor Dame Ann Dowling, 2015

Page viewed: 7:52 pm on 17 November 2026

This is the website for UKRI: our seven research councils, Research England and Innovate UK. Let us know if you have feedback or would like to help improve our online products and services.